Drug safety in the pharmacotherapy of Parkinson's disease

被引：0
|
作者：
Mueller-Rebstein, S.
Trenkwalder, C.
Ebentheuer, J.
Culmsee, C.
Hoeglinger, G.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1929
引用
收藏
页码：S634 / S634
页数：1
相关论文
共 50 条
  • [21] Recent important trials of pharmacotherapy in Parkinson's disease
    Doggrell, SA
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 1025 - 1028
  • [22] Management of Parkinson's disease: Current and future pharmacotherapy
    Kakkar, Ashish Kumar
    Dahiya, Neha
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 750 : 74 - 81
  • [23] Depression in Parkinson's disease. The role of pharmacotherapy
    Wierzbinski, Piotr
    Sobow, Tomasz
    AKTUALNOSCI NEUROLOGICZNE, 2018, 18 (01): : 14 - 20
  • [24] Literature Review on History and Pharmacotherapy of Parkinson`s Disease
    Supriya, P.
    Rajaram, S.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (47A) : 839 - 849
  • [25] Evaluation of efficacy and safety of the novel drug hemantane in patients with Parkinson's disease
    Valdman, Elena
    Seredenin, Sergey
    Avakian, Gagik
    Katunina, Elena
    Levin, Oleg
    Vasenina, Elena
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 313 - 313
  • [26] Impact of Pharmacotherapy on Quality of Life in Patients with Parkinson's Disease
    Martinez-Martin, Pablo
    Rodriguez-Blazquez, Carmen
    Forjaz, Maria Joao
    Kurtis, Monica M.
    CNS DRUGS, 2015, 29 (05) : 397 - 413
  • [27] Computer-assisted selection of pharmacotherapy in Parkinson's disease
    Khutorskaya, OE
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1998, 98 (12): : 25 - 28
  • [28] Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease
    F Fumagalli
    G Racagni
    M A Riva
    The Pharmacogenomics Journal, 2006, 6 : 95 - 104
  • [29] Cost factors of early diagnostics and pharmacotherapy of Parkinson's disease
    Kuchinke, B. A.
    Akmaz, B.
    Janetzky, W.
    NERVENHEILKUNDE, 2012, 31 (11) : 844 - 849
  • [30] The role of iron in neurodegeneration - Prospects for pharmacotherapy of Parkinson's disease
    Jellinger, KA
    DRUGS & AGING, 1999, 14 (02) : 115 - 140
12345